Explorez tous les épisodes de MDS Podcast
Plongez dans la liste complète des épisodes de MDS Podcast. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.
| Date | Titre | Durée | |
|---|---|---|---|
| 01 Oct 2024 | What you missed: MDS Congress Day 4 | ||
The last full day of #mdscongress 2024 was packed full of sessions and other activities. Prof. Huw Morris dives into the learnings from the day and recollects the excitement surrounding the much-loved Video Challenge. | |||
| 08 Jul 2020 | Late-stage Parkinsonism: Do we know enough? | ||
Dr. Michele Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage? Read the article | |||
| 18 May 2020 | How to manage Parkinson's disease and related disorders, and is there a link between COVID and PD? | ||
Dr. Michele Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease? Read the article | |||
| 16 May 2022 | Approach to reviewing a review article | ||
For the sixth episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Christine Klein to discuss the approach to reviewing a review article. | |||
| 27 Jun 2022 | How not to conduct a peer review: Fatal, avoidable errors. | ||
In this episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Jose Obeso to discuss some points on how NOT to conduct a peer review. | |||
| 02 May 2022 | How to review an original scientific article | ||
For this episode of our special series focused on the peer review process, Dr. Alana Kirby speaks with Dr. Tony Lang about how to approach reviewing an original scientific article. | |||
| 25 Apr 2022 | Infectious agents as drivers of synucleinopathies? | ||
Dr. Tiago Outeiro interviews Dr. Morgane Linard about the recently published article, "Infectious Agents as Potential Drivers of α-Synucleinopathies." Read the Article. Journal CME will be available for this article until March 18, 2023. | |||
| 18 Apr 2022 | Reviewing case reports and clinical series | ||
Dr. Daniel Di Luca discusses how to approach and review case reports and case series in movement disorders with Prof. Kailash Bhatia. | |||
| 09 May 2022 | Rasagiline in PD: Does it change disease progression? And how do we measure it? | ||
A recent trial showed no benefit of 1mg rasagiline versus placebo on 1-year progression in an early Parkinson's disease cohort. The investigators used a novel method to track disease progression with MRI, apart from usual clinical standards. Dr. David Vaillancourt shares the results of this trial recently published in the Movement Disorders Journal. Read the article. | |||
| 31 Aug 2023 | Award Article: Have we forgotten what tics are? | ||
In this special issue celebrating the Movement Disorders Clinical Practice journal Research Article of the Year 2023, Sara Schaefer discusses tic phenomenology in primary tic disorders vs. functional tic-like disorders with Dr. Tamara Pringsheim. Read the article » | |||
| 22 Aug 2022 | Implanted system for orthostatic hypotension in multiple-system atrophy | ||
Dr. Sara Schaefer speaks with Drs. Gregoire Courtine and Jocelyne Bloch about the use of an implanted spinal cord stimulator for the treatment of orthostatic hypotension in multiple-system atrophy.
Read the article. | |||
| 18 Jul 2022 | MDS Criteria for the diagnosis of Multiple System Atrophy: New features and implications | ||
Dr. Eduardo de Pablo-Fernández interviews Dr. Iva Stankovic and Prof. Gregor Wenning on the newly published MDS Criteria for the Diagnosis of Multiple System Atrophy. Read the article.
Journal CME will be available for this article until June 17, 2023. | |||
| 30 Jun 2022 | Parkinson's disease medications during hospitalization | ||
Dr. Sara Schaefer and Dr. Georgia Richard discuss the breakdown in medication prescribing and administration in hospitalized Parkinson's patients, and potential strategies for improvement. Read the article. | |||
| 06 Jun 2022 | Pesticide exposure and dream-enacting behavior | ||
Dr. Hugo Morales interviews Dr. Chen Honglei about his most recent paper "High Pesticide Exposure Events and Dream-Enacting Behaviors Among US Farmers" published in the Movement Disorders journal. Read the article.Journal CME will be available for this article until May 20, 2023. | |||
| 13 Jun 2022 | The Ethics of Peer Review | ||
For this episode of our special series focused on the peer review process, Dr. Alana Kirby speaks with Prof. Claudia Trenkwalder about the ethics of peer review. | |||
| 23 May 2022 | Unmet needs of women with Parkinson's disease: Gaps and controversies | ||
Dr. Sarah Lidstone interviews Dr. Indu Subramanian about her recent paper, "Unmet needs of women with Parkinson's disease: Gaps and Controversies," in Movement Disorders. Read the article. | |||
| 14 Oct 2020 | Randomized controlled trial of exercise on objective and subjective sleep in Parkinson's disease | ||
Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from Movement Disorders" on the effects of exercise on sleep in Parkinson's disease. Read the article | |||
| 14 Oct 2020 | Value of invivosynuclein deposits in Parkinson's disease - Asystematic review and metaanalysis | ||
Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from Movement Disorders" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. Read the article | |||
| 09 Nov 2020 | Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers | ||
Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. Read the article | |||
| 31 Mar 2020 | Antibiotics and Parkinson's disease | ||
In this issue Dr. Filip Sheperjans shares the results of the article published in the March 2020 issue of the Movement Disorders journal on the effect of antibiotic exposure on the risk of developing Parkinson's disease. Read the article | |||
| 21 Feb 2020 | Integrated therapy for functional movement disorders | ||
Dr. Sara Schaefer discusses with Dr. Sarah Lidstone her recent paper in Movement Disorders Clinical Practice about a novel, multidisciplinary therapeutic intervention for functional movement disorders patients. Read the article | |||
| 26 May 2020 | Practicing medicine in time of pandemic and future of Movement Disorders medical practice | ||
Dr. Michele Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice? | |||
| 26 May 2020 | Interview with the president on the MDS activities during the COVID crisis | ||
In this interview the president of the MDS, Prof. Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting. | |||
| 11 Apr 2022 | Does glucocerebrosidase activity correlate with disease risk or phenotype severity in Parkinson's disease? | ||
A discussion with Dr. Avner Thaler on the findings and implications of a study on the background of importance of GBA mutations and GCase activity in Parkinson's disease. Read the Article. | |||
| 21 Mar 2022 | When to accept or decline an invitation to review | ||
For the second episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Günther Deuschl about the crucial first part of the peer review process - identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review. | |||
| 17 Sep 2022 | Award Article: A Multi-Step Model of Parkinson's Disease Pathogenesis | ||
"A Multi-Step Model of Parkinson's Disease Pathogenesis" was awarded "Best Research Article of the Movement Disorders journal for 2022." Dr. Michele Matarazzo interviews the first author, Dr. Campbell Le Heron. Read the article | |||
| 17 Sep 2022 | Award Replay: MDS Criteria for the diagnosis of Multiple System Atrophy: New features and implications | ||
A re-release of the episode featuring the recently-awarded "Best Review article of 2022 from the Movement Disorders journal" article, titled "The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy." Read the article. | |||
| 07 Oct 2024 | Past, present, future: An interview with MDS President • 2024 MDS Congress | ||
Dr. Victor Fung sat down with Dr. Michele Matarazzo at the #mdscongress to reflect on the advice from his predecessors and how that is helping him achieve his goals as MDS President. | |||
| 31 Aug 2023 | Award Article: Long duration levodopa response and neuroplasticity in Parkinson’s disease | ||
In this special issue celebrating the Movement Disorders journal Research Article of the Year 2023, Sara Schaefer discusses with Dr. Mario Zappia the effects of the short vs long duration responses to levodopa on cortical excitability and neuroplasticity in response to motor learning tasks in early Parkinson’s disease patients. Read the article » | |||
| 22 Mar 2019 | Advanced therapies for Parkinson's disease: Are they all the same? | ||
Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the Movement Disorders journal. Read the article | |||
| 20 Feb 2019 | Is benign hereditary chorea really benign? | ||
Dr. Mered Parnes discusses with Dr. Sara Schaefer his article on benign hereditary chorea recently published in the January 2019 issue of the Movement Disorders Clinical Practice. Read the article | |||
| 06 Jun 2019 | Long-term outcomes of focused ultrasound in essential tremor | ||
Dr. Jin Woo Chang shares the results of 4-year follow-up of MR-guided focused ultrasound thalamotomy in essential tremor. In his article, recently published in the Movement Disorders journal, he analyzes whether the efficacy of this procedure is sustained over time. Read the article | |||
| 06 Nov 2019 | Atypical Parkinsonisms | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Gesine Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials. | |||
| 11 Feb 2019 | The Mediterranean diet in Parkinson's disease | ||
Dr. Nikolaos Scarmeas discusses with Dr. Michele Matarazzo the results of his article about the impact of the Mediterranean diet on the risk of Parkinson’s disease, published in the January 2019 issue of the Movement Disorders journal. Read the article | |||
| 30 Apr 2019 | When should dopaminergic treatment be initiated in Parkinson's disease? | ||
Dr. Ruth Schneider discusses with Dr. Sara Schaefer about the article she recently published in the Movement Disorders Clinical Practice that investigates the outcomes of early vs delayed start of dopaminergic medication in Parkinson's disease. Read the article | |||
| 20 Jan 2020 | White matter changes in Huntington's disease | ||
Dr. Sara Schaefer discusses with Dr. Sarah Gregory her recent study on neuroimaging changes and fluid biomarkers in Huntington's disease, and how those may be used to better characterize the biological basis for neurodegeneration in this disease Read the article | |||
| 01 Mar 2021 | Acetylcholine nuclei atrophy predicts gait changes in Parkinson's disease | ||
Dr. Michele Matarazzo interviews Dr. Nicola Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease. Read the article | |||
| 01 Feb 2021 | Anxiety in parkinson's disease and its correlates in mri-based functional connectivity | ||
Dr. Michele Matarazzo interviews Dr. Rosa De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the Movement Disorders journal.Read the article | |||
| 17 Jan 2022 | Approach to neuroimaging in Parkinsonisms | ||
Dr. Sara Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in Movement Disorders Clinical Practice on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms." Read the article | |||
| 01 May 2021 | Autophagy in levodopa-induced dyskinesia: A new potential therapeutic target | ||
Dr. Michele Matarazzo interviews Prof. Gilberto Fisone about the role of autophagy in levodopa-induced dyskinesia. Read the article | |||
| 22 Sep 2020 | Deep brain stimulation for Parkinson, beyond motor improvement: Social and occupational outcomes | ||
In this interview, Prof. Günther Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease. Read the article | |||
| 14 Oct 2019 | Definition and characteristics of early onset PSP: A different disease? | ||
In this interview with Dr. Edwin Jabbari, we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the Movement Disorders journal. Read the article | |||
| 01 Apr 2021 | Electroconvulsive therapy in movement disorders | ||
Dr. Sara Schaefer discusses with Dr. Pedro Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders. Read the article | |||
| 07 Feb 2020 | Fine tuning DBS in Parkinson's disease. How much can we improve? | ||
Dr. Viswas Dayal discusses with Dr. Michele Matarazzo how adjusting the pulse width of deep brain stimulation could impact Parkinson's disease, highlighting the results of the paper he recently published in the Movement Disorders journal. Read the article | |||
| 06 Aug 2019 | Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker? | ||
Dr. Niels Bergsland discusses with Dr. Michele Matarazzo the results of the article he recently published in the Movement Disorders journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions. Read the article | |||
| 20 Sep 2020 | Interview with Dr. Jon Stoessl on Preprints in the COVID-Era | ||
Preprint articles of scientific results have been thrust into the spotlight due to the desire for rapid results pertaining to COVID-19. Here, we dive into the trend with Movement Disorders’ editor, Dr. Jon Stoessl. Read the article | |||
| 24 Oct 2019 | Dystonia | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Hyder Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group. | |||
| 18 Oct 2019 | Education at the MDS | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Ronald Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee. | |||
| 23 Oct 2019 | Huntington's disease | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Sarah Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next. Read the article | |||
| 24 Oct 2019 | Neuroimaging in movement disorders | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Antonio Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms. | |||
| 18 Oct 2019 | Introduction and functional movement disorders | Congress 2019 | ||
Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Sara Schaefer interviews Dr. Kathrin LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more. | |||
| 06 Nov 2019 | New technologies in movement disorders | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Alberto Espay about technology in movement disorders, highlighting recent advances and the goal of the MDS to create a platform that will combine technology-based data and e-diaries. | |||
| 06 Nov 2019 | Parkinson's disease and Lewy body disorders | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. K. Ray Chaudhuri about news in Parkinson’s disease and Lewy body dementia, including new treatments, scales and other advances in early and late-stage PD. Read the article | |||
| 06 Nov 2019 | Tic disorders and Tourette syndrome | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Christos Ganos about the newly created MDS Tic Disorders and Tourette Syndrome Study Group, and the main news breakthroughs in the field, that have been discussed during the MDS Congress. | |||
| 06 Nov 2019 | Tremor | Congress 2019 | ||
As part of the MDS Congress 2019 Special Issue, Dr. Michele Matarazzo interviews Dr. Rodger Elble about recent advances in tremor classification, diagnosis and treatment approaches, and about the future plans of the MDS Tremor study group to overcome current challenges for clinicians and researchers. | |||
| 30 Aug 2019 | MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis | ||
Dr. Farwa Ali discusses with Dr. Sara Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research. Read the article | |||
| 01 Jun 2021 | Cognitive and visuospatial abilities in dystonia | ||
Dr. Sara Schaefer speaks with Dr. Carlos Camargo about the non-motor and prodromal features of dystonia. Read the article | |||
| 01 Nov 2019 | The treatment of upper limb tremor with botulinum toxin: An individualized approach | ||
Dr. Sara Schaefer discusses with Dr. Jordan Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients. Read the article | |||
| 01 Sep 2021 | Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients | ||
Dr. Sara Schaefer speaks with Dr. Anumantha Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease. Read the article | |||
| 30 Sep 2021 | An interview with Claudia Trenkwalder | Congress 2021 | ||
Dr. Sara Schaefer discusses with Dr. Claudia Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS. | |||
| 06 Nov 2020 | The impact of COVID-19 on scientific research activities | ||
In this interview, Prof. Brit Mollenhauer provides insight into how researchers have been coping with the COVID-19 pandemic. Read the article | |||
| 20 Nov 2020 | Neurofilament light chain in Parkinson's disease | ||
Dr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study. Read the article | |||
| 04 Jan 2021 | Neuroinflammation in Parkinson's disease | ||
Dr. Mcihele Matarazzo interviews Dr. David Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets. Read the article | |||
| 01 Jan 2020 | Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough? | ||
Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. Read the article | |||
| 01 Feb 2021 | Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough? | ||
Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. Read the article | |||
| 28 Jun 2019 | Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate? | ||
Benjamin Deck discusses with Dr. Schaefer the article he recently published in the Movement Disorders Clinical Practice on the patient vs. care partner assessment of cognition in Parkinson's disease. Read the article | |||
| 07 Mar 2022 | Overview and core components of the peer review process | ||
For the first episode of the special series focused on the peer review process, Dr. Daniel Di Luca speaks with Dr. Christopher Goetz about the importance and most important aspects of a peer review. | |||
| 04 Apr 2022 | What are journal editors looking for in a good review? | ||
This is the third episode of the special series focused on the peer review process. In this episode, Dr. Alana Kirby speaks with Dr. Jon Stoessl about what journal editors are looking for in a good review. He provides practical tips for writing an effective peer review. | |||
| 18 Oct 2021 | Variability of movement disorders: The influence of sensation | ||
Dr. Michele Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders journal, highlighting the impact on several factors on the variability of movement disorders. Read the article | |||
| 18 Oct 2021 | Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target? | ||
Dr. Michele Matarazzo speaks with Prof. Ryosuke Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. Read the article | |||
| 18 Oct 2021 | The most impactful paper related to movement disorders therapy in the 20th century | ||
Dr. Sara Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today. Read the article | |||
| 18 Oct 2021 | Swim for Parkinson: Swimming together to improve together | ||
The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD. | |||
| 09 Jan 2021 | Scar dancing syndrome | ||
Dr. Yiwen Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs. Read the article | |||
| 13 Dec 2021 | Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology | ||
Dr. Günter Hoglinger discusses the article he recently published in the Movement Disorders journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations. Read the article | |||
| 01 Aug 2021 | TikTok tics | ||
Dr. Sara Schaefer speaks with Dr. Caroline Olvera about trending videos of tics and other neurological syndromes on social media. Read the article | |||
| 15 Feb 2022 | Neuropsychiatric features of punding and hobbyism in Parkinson's disease | ||
Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease," by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice. Read the article. | |||
| 12 Jun 2023 | A cross-sectional study of PPMI participants using alpha-synuclein seed amplification as a biomarker | ||
In this episode Dr. Tiago Outeiro talks with Dr. Andrew Siderowf about the exciting new results in his most recent publication on alpha-synuclein seed amplification assay.
Read the article. | |||
| 29 Apr 2024 | A new pathway to find structural variations in inherited neurological cases - the SCA4 example | ||
Dr. Sarah Camargos interviews Dr. Zhonghbo Chen and Prof. Henry Houlden, first and senior author of a MDJ paper exploring a GGC repeat expansion in the ZFHX3 gene associated with spinocerebellar ataxia type 4. They describe a criative methodology to find a gene in a family with a Swedish ancestry.
Journal CME is available until April 04, 2025 Read the article. | |||
| 15 Jul 2024 | A post-hoc analysis of the Prasinezumab trial in early Parkinson's disease | ||
Dr. Gennaro Pagano discusses the findings of the post-hoc analysis of the PASADENA trial, a study using the monoclonal antibody Prasinezumab directed at aggregated α-synuclein, where motor progression trajectories differed between active and placebo groups. Read article » | |||
| 18 Sep 2023 | Advancements in Dystonia Treatments | Congress 2023 | ||
What innovations in dystonia treatments do we have to look forward to? Dr. Mark Edwards sits down with Dr. Sarah Camargos to answer that vary question.
2023 Congress virtual access | |||
| 01 Oct 2022 | Advances in Supranuclear Palsy Research | Congress 2022 | ||
Despite the challenge of studying rare conditions like PSP, Dr. Yaroslau Compta discusses with Dr. Eduardo de Pablo-Fernández how leaps forward in recent advances could make us rethink the way we approach the condition. | |||
| 01 Oct 2022 | An Interview with MDS President Francisco Cardoso | Congress 2022 | ||
MDS President Francisco Cardoso shares with Dr. Michele Matarazzo the important takeaways from this year's Congress that will shape the future of movement disorders and the Society. | |||
| 21 Oct 2024 | An online mindfulness-based group intervention for tics | ||
Dr. Hannah E. Reese and Mr. W. Alan Brown discuss their pilot study of a mindfulness-based group virtual intervention for tic disorders, that was co-developed with patients.
Journal CME is available until August 21, 2025 Read the article. | |||
| 27 Sep 2024 | MDCP Research Article of the Year: The Role of Levodopa Challenge in Predicting the Outcome of STN DBS | ||
Award Replay: Dr. Eduardo Fernandez interviews Professor Günther Deuschl and Dr. Robin Wolke on their article on the challenges levodopa poses when predicting the outcome of subthalamic deep brain stimulation — which was recently named the Movement Disorders Clinical Practice journal Research Article of the Year.
Read the article | |||
| 01 Oct 2022 | Basic Science Updates in Movement Disorders | Congress 2022 | ||
Which emerging areas of movement disorders research are set to advance in the coming years? And how is that already beginning to affect clinical care? Prof. Jose Obeso shares about this and other key scienctific shifts with Prof. Tiago Outeiro. | |||
| 07 Oct 2024 | Better understanding functional movement disorders • 2024 MDS Congress | ||
Dr. Alexander Lehn breaks down functional movement disorders; what is happening in the brain, what are the potential risk factors and what future treatments and clinical trials we have to look forward to. | |||
| 06 Feb 2023 | Beyond “torsion": non-motor features of dystonia | ||
In part 2 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Davide Martino on the non-motor features of dystonia. | |||
| 14 Mar 2022 | Bilateral focused ultrasound thalamotomy for essential tremor, is it safe? | ||
Prof. Andres Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients. Read the article. | |||
| 07 Oct 2024 | Biomarkers and basic science research • 2024 MDS Congress | ||
Prof. Brit Mollenhauer shares her excitement about basic science, including biomarker research, and how she believes MDS’s diversity can help foster more collaboration between clinicians and basic scientists. | |||
| 17 Oct 2022 | COVID-19 and the Risk of Parkinsonism | ||
Dr. Sara Schaefer discusses with Prof. Richard Smeyne how viruses including COVID-19 increase the susceptibility to oxidative stress-induced parkinsonism in mouse models, the historical evidence to support a virus-parkinsonism link, the biological basis for this correlation, and ways it may be prevented.
Journal CME is available until July 29, 2023 Read the article. | |||
| 28 May 2024 | CSF1R-related disorder in China | ||
Dr. Sara Schaefer speaks with Doctors Xiaojun Huang and Jingying Wu about the phenotypic and genotypic spectrum of CSF1R-related disorder in a Chinese population, including unique clinical and radiographic characteristics.
Journal CME is available until May 21, 2025 Read the article. | |||
| 14 Nov 2022 | Can dogs diagnose Parkinson's disease? | ||
Dr. Sarah Lidstone interviews Dr. Chang-Qing Gao & Prof. Ji-fung Guo about their recent research on the sensitivity of sniffer dogs for diagnosing Parkinson's disease.
Read the article. | |||
| 13 Feb 2023 | Clozapine in Parkinson's disease: Why, when and how? | ||
Clozapine is a antipsychotic drug that has been marketed for decades. In this interview, Dr. Friedman shares his thoughts on its utility in Parkinson's disease along with some practical advices on how to use it in the clinic.
Read the article. | |||
| 15 Apr 2024 | Concomitant pathologies and their clinical impact in multiple system atrophy | ||
Dr. Eduardo Fernandez discusses with Dr. Hiroaki Sekiya the surprising findings of his study evaluating the presence of concomitant pathologies and how they impact the disease progression in a large cohort of patients with MSA from the Mayo Clinic brain bank.
Read the article | |||
| 13 Mar 2023 | Current and future approaches to treatment of dystonia | ||
In part 5 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Jill Ostrem about current and future approaches to treatment of dystonia. | |||
| 15 Jan 2024 | Deep brain stimulation for GBA-related Parkinson's disease: is it a reasonable option? | ||
In this special issue Dr. Avenali and Prof. Valente share the results on a large cohort study investigating the results and risks of deep brain stimulation in people with Parkinson's disease carrying a GBA mutation.
Read the article | |||
| 12 Dec 2022 | Deep brain stimulation for Parkinson's disease dementia: are we there yet? | ||
Dr. Michele Matarazzo interviews Prof. Marjan Jahanshahi on the long term results of the clinical trial of deep brain stimulation of the nucleus basalis of Meynert in people with Parkinson's disease dementia. In the discussion Prof. Jahanshahi shares thoughts on the future directions of the field.
Read the article. | |||
| 01 May 2023 | Deep brain stimulation in Parkinson's disease with cognitive impairment: real-world evidence | ||
Deep brain stimulation (DBS) has long been considered a risky procedure for people with Parkinson's disease and cognitive impairment. In this interview, Dr. Miocinovic presents real-world data, showing that DBS might be safe and useful in carefully selected patients with moderate cognitive impairment.
Read the article. | |||
| 13 Jan 2025 | Defining Parkinson's disease: where we are, where we are headed | ||
Dr. Michele Matarazzo interviews Dr. Victor Fung, President of the International Parkinson and Movement Disorder Society and lead author of the recent viewpoint published in the Movement Disorders journal. Together, they explore the biological definition and classification of Parkinson's disease, discussing its key insights, future prospects, and the implications of recent advances in the field.
Read the article. | |||
| 15 May 2023 | Diagnosis of Late-Onset Wilson's Disease | ||
Dr. Christelle Nilles talks with Dr. Hugo Morales Briceno about the clinical presentations of Wilson’s disease patients with onset after 40 years and the challenges of diagnosing patients with atypical neurological manifestations.
Read the article. | |||
Améliorez votre compréhension de MDS Podcast avec My Podcast Data
Chez My Podcast Data, nous nous efforçons de fournir des analyses approfondies et basées sur des données tangibles. Que vous soyez auditeur passionné, créateur de podcast ou un annonceur, les statistiques et analyses détaillées que nous proposons peuvent vous aider à mieux comprendre les performances et les tendances de MDS Podcast. De la fréquence des épisodes aux liens partagés en passant par la santé des flux RSS, notre objectif est de vous fournir les connaissances dont vous avez besoin pour vous tenir à jour. Explorez plus d'émissions et découvrez les données qui font avancer l'industrie du podcast.
© My Podcast Data